KFO
Kopp Family Office Portfolio holdings
AUM
$155M
1-Year Return
12.37%
This Quarter Return
-8.8%
1 Year Return
+12.37%
3 Year Return
+32.09%
5 Year Return
+62.77%
10 Year Return
–
AUM
$146M
AUM Growth
-$11.7M
(-7.4%)
Cap. Flow
+$1.59M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
3
Reduced
2
Closed
–
Top Buys
| 1 |
Vericel Corp
VCEL
|
+$5.95M |
| 2 |
FIVE9
FIVN
|
+$799K |
| 3 |
XENT
Intersect ENT, Inc
XENT
|
+$150K |
Top Sells
| 1 |
NeoGenomics
NEO
|
+$5.13M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$175K |
Sector Composition
| 1 | Healthcare | 97.24% |
| 2 | Technology | 2.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.03B
| $129M | 88.3% |
4,658,835
-185,790
| -4% | -$5.13M |
|
|
2
Vericel Corp
VCEL
$1.62B
| $6.86M | 4.71% |
748,255
+648,455
| +650% | +$5.95M |
|
|
SRGA
3
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $6.17M | 4.23% |
120,257
-3,404
| -3% | -$175K |
|
|
4
FIVE9
FIVN
$2B
| $2.98M | 2.05% |
38,995
+10,445
| +37% | +$799K |
|
|
XENT
5
DELISTED
Intersect ENT, Inc
XENT
| $1.04M | 0.71% |
87,630
+12,630
| +17% | +$150K |
|